Oman's government will remain thoroughly committed to developing the country's pharmaceutical and healthcare sectors; though it is unlikely they will advance to the dominant status of neighbouring countries Saudi Arabia and the UAE. Despite a relatively attractive business environment, multinational drugmakers will prefer to opt for local contract manufacturing or importing pharmaceutical goods and will be unlikely to establish a direct manufacturing presence. As the Omani government continues to fund the majority of healthcare expenditure, private sector growth will outpace that of the public sector, owing to investment incentives and the rollout of compulsory health insurance schemes. The private sector will play a pivotal role in healthcare expansion in Oman over the long term.

Key View

SWOT

Industry Forecast

Industry Risk/Reward Index

Regulatory Development

Market OverviewCompetitive LandscapeCompany Profile

Oman Demographic OutlookPharmaceuticals & Healthcare Glossary

Pharmaceuticals & Healthcare Methodology